Lung toxicity in radioiodine therapy of thyroid carcinoma: development of a dose-rate method and dosimetric implications of the 80-mCi rule

G Sgouros, H Song, PW Ladenson… - Journal of Nuclear …, 2006 - Soc Nuclear Med
Based on an extensive dataset analyzed by Benua et al., a whole-body retention threshold
of 2.96 GBq (80 mCi) at 48 h has been used to limit the radioactivity of 131I administered to …

Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases

H Song, B He, A Prideaux, Y Du, E Frey… - Journal of nuclear …, 2006 - Soc Nuclear Med
The lungs are the most frequent sites of distant metastasis in differentiated thyroid
carcinoma. Radioiodine treatment planning for these patients is usually performed following …

Assessment of radioiodine clearance in patients with differentiated thyroid cancer

F Tabei, I Neshandar Asli… - Radiation protection …, 2012 - academic.oup.com
Radioiodine (131I iodide) has long been a safe, effective and widely used treatment in the
management of differentiated thyroid cancer (DTC). Concerns regarding stochastic …

Thyroid Cancer: Radiation Safety Precautions in 131I Therapy Based on Actual Biokinetic Measurements

B Liu, W Peng, R Huang, R Tian, Y Zeng, A Kuang - Radiology, 2014 - pubs.rsna.org
Purpose To formulate radiation precautions for patients with thyroid cancer who are
undergoing thyroid hormone withdrawal–induced hypothyroidism and iodine 131 (131I) …

The use of dosimetry in the treatment of differentiated thyroid cancer.

M Lassmann, H Hänscheid, FA Verburg… - The Quarterly Journal …, 2011 - europepmc.org
The standard treatment for the ablation of thyroid remnant tissue following surgery as well as
for the treatment of iodine avid metastases in patients suffering from differentiated thyroid …

Radioactive body burden measurements in 131 iodine therapy for differentiated thyroid cancer: Effect of recombinant thyroid stimulating hormone in whole body 131 …

R Ravichandran, A Al Saadi… - World Journal of Nuclear …, 2014 - thieme-connect.com
Protocols in the management of differentiated thyroid cancer, recommend adequate thyroid
stimulating hormone (TSH) stimulation for radioactive 131 I administrations, both for imaging …

Physics aspects of setting up a multicenter clinical trial involving internal dosimetry of radioiodine treatment of differentiated thyroid cancer.

J Taprogge, F Leek, GD Flux - … of the Italian Association of Nuclear …, 2019 - europepmc.org
The field of molecular radiotherapy is expanding rapidly, with the advent of many new
radiotherapeutics for the treatment of common as well as for rare cancers. Treatment …

Radiation dose assessment in radioiodine therapy. Dose-response relationships in differentiated thyroid carcinoma using quantitative scanning and PET

MEA O'Connell, MA Flower, PJ Hinton… - Radiotherapy and …, 1993 - Elsevier
Dose-response charts have been constructed to determine the tumouricidal dose for
differentiated thyroid carcinoma metastases and thus enable precise activities of radioiodine …

Thyroid carcinoma with high levels of function: treatment with 131I

JC Sisson, JE Carey - Journal of Nuclear Medicine, 2001 - Soc Nuclear Med
In some patients with well-differentiated thyroid carcinoma, dosimetry is necessary to avoid
toxicity from therapy and to guide prescription of the administered activity of radioiodine …

[PDF][PDF] Thyroid cancer dosimetry using clearance fitting

EE Furhang, SM Larson, P Buranapong… - Journal of Nuclear …, 1999 - Soc Nuclear Med
Since 1962, Memorial Sloan Kettering Cancer Center has used an individually optimized
dosimetry method for patients with thyroid carcinoma undergoing radioiodine therapy. This …